Assignee
INTREXON ACTOBIOTICS N V
BE·8 granted patents·18 citations·filing 2017–2023
Top patents by PatentIndex Score
8 records- 0193US10905727B2Compositions and methods for the treatment of type 1 diabetesINTREXON ACTOBIOTICS N V·Filed 2017·Granted Feb 2, 2021·7 cites·8 claims
- 0292US11786567B2Compositions and methods for the treatment of type 1 diabetesINTREXON ACTOBIOTICS N V·Filed 2021·Granted Oct 17, 2023·2 cites·17 claims
- 0391US11384123B2Mucoadhesive microorganismINTREXON ACTOBIOTICS N V·Filed 2020·Granted Jul 12, 2022·2 cites·19 claims
- 0491US10808014B2Mucoadhesive microorganismINTREXON ACTOBIOTICS N V·Filed 2017·Granted Oct 20, 2020·4 cites·32 claims
- 0589US10858663B2Genetically modified bacteria stably expressing IL-10 and insulinINTREXON ACTOBIOTICS N V·Filed 2017·Granted Dec 8, 2020·3 cites·31 claims
- 0682US12246046B2Compositions and methods for the treatment of type 1 diabetesINTREXON ACTOBIOTICS N V·Filed 2023·Granted Mar 11, 2025·0 cites·13 claims
- 0778US12252516B2Mucoadhesive microorganismINTREXON ACTOBIOTICS N V·Filed 2022·Granted Mar 18, 2025·0 cites·22 claims
- 0870US11549118B2Genetically modified bacteria stably expressing IL-10 and insulinINTREXON ACTOBIOTICS N V·Filed 2020·Granted Jan 10, 2023·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when INTREXON ACTOBIOTICS N V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →